Follow the Pharma Outreach Series
Follow the live outreach campaign to find the right next home for Art Pharma®.
Art Pharma®
NEWS RELEASE
Thursday, November 12, 2026
Decision by December 31, 2026
Art Pharma products are currently unavailable, and we do not have a confirmed restock date.
After more than 10 years in the iodine supplementation market, Art Pharma has reached a point where its next stage requires a decision.
We are currently considering two paths.
Acquisition of the Brand & Intellectual Property
The complete acquisition of the Art Pharma® (Canada & USA) brand and the associated intellectual property and digital assets.
This represents a different path: ownership and control of the acquired assets would transfer to the purchaser.
Founder Funded
The opportunity is to move beyond simply selling Lugol’s iodine online and bring iodine supplementation closer to people through education and personal interaction.
We see an opportunity to bring that experience closer to customers in a more direct and accessible way.
Executing the plan requires a significant capital investment. More importantly, it requires a significant commitment of the founder’s time and focus at a point when the main chemical distribution business is entering its next stage of growth.
Whether that investment of capital and time makes sense is the decision that must now be made.
For Our Customers
To the customers who continue to visit, write and ask when our products will return: thank you.
This decision is being made carefully because what happens next matters.
We will announce Art Pharma’s direction no later than December 31, 2026.
Follow the Pharma Outreach Series
Follow the live outreach campaign to find the right next home for Art Pharma®.
Art Pharma Lugol's Iodine®
Iodine and Potassium Iodide
Art Pharma KI Solution®
Potassium Iodide Solution
Art Pharma KI Solution Plus®